Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
562-02-009 ISMRM Abstract

Distinguishing benign and malignant masses of breast tumors in DCE-MRI using a spatial-temporal encoding model

Primary: Analysis Methods - Classification and Prediction
Secondary: Analysis Methods - Data Processing
562-02-009 · Breast MRI and the Role of AI · Wednesday, 13 May, 9:15 AM–10:10 AM · Digital Posters Row C
Keywords: Deep learning Multi-centre DCE-MRI Breast Tumor Time-intensity curve
Accepted
Tianyi Zhang1, Lin Li2, Yuan Guo3, Jianming Rong1, Yuanhao Li1, Ya Ren2, Meng Wang2, Shuluan Chen2, Jie Wen2, wei cui4, Dehong Luo2, Zhou Liu 2, Zhenxing Huang1
1Research Center for Medical AI, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China
2Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China
3Department of Radiology, Guangzhou First People’s Hospital, Guangzhou，Guangdong, China
4MRI Research, GE Healthcare, Beijing, China
Presenting Author: Zhou Liu

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2024;74(3):229-263.
2. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. Jama 2004;292(11):1317-1325.
3. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: a cancer journal for clinicians 2007;57(2):75-89.
4. Lehman CD, Isaacs C, Schnall MD, Pisano ED, Ascher SM, Weatherall PT, Bluemke DA, Bowen DJ, Marcom PK, Armstrong DK. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007;244(2):381-388.
5. Rahmat K, Mumin NA, Hamid MT, Hamid SA, Ng WL. MRI breast: current imaging trends, clinical applications, and future research directions. Current Medical Imaging Reviews 2022;18(13):1347-1361.
6. Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA. Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging. Investigative radiology 2018;53(10):587-595.
7. Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P. Development, standardization, and testing of a lexicon for reporting contrast‐enhanced breast magnetic resonance imaging studies. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 2001;13(6):889-895.
8. Alteri R, Bandi P, Brinton L, Casares C, Cokkinides V, Gansler T. Breast Cancer Facts & Figures 2011–2012. Atlanta: American Cancer Society. Inc, 2011.
9. Yao J, Chen J, Chow C. Breast tumor analysis in dynamic contrast enhanced MRI using texture features and wavelet transform. IEEE Journal of selected topics in signal processing 2009;3(1):94-100.
10. Agner SC, Xu J, Fatakdawala H, Ganesan S, Madabhushi A, Englander S, Rosen M, Thomas K, Schnall M, Feldman M. Segmentation and classification of triple negative breast cancers using DCE-MRI. 2009 IEEE international symposium on biomedical imaging: From nano to macro: IEEE, 2009; p. 1227-1230.
11. Debbi K, Habert P, Grob A, Loundou A, Siles P, Bartoli A, Jacquier A. Radiomics model to classify mammary masses using breast DCE-MRI compared to the BI-RADS classification performance. Insights into Imaging 2023;14(1):64.
12. Rasti R, Teshnehlab M, Phung SL. Breast cancer diagnosis in DCE-MRI using mixture ensemble of convolutional neural networks. Pattern Recognition 2017;72:381-390.
13. Hizukuri A, Nakayama R, Nara M, Suzuki M, Namba K. Computer-aided diagnosis scheme for distinguishing between benign and malignant masses on breast DCE-MRI images using deep convolutional neural network with Bayesian optimization. Journal of Digital Imaging 2021;34(1):116-123.
14. Gravina M, Marrone S, Sansone M, Sansone C. DAE-CNN: Exploiting and disentangling contrast agent effects for breast lesions classification in DCE-MRI. Pattern Recognition Letters 2021;145:67-73.
15. Tang W, Jin C, Kong Q, Liu C, Chen S, Ding S, Liu B, Feng Z, Li Y, Dai Y. Development and validation of an MRI spatiotemporal interaction model for early noninvasive prediction of neoadjuvant chemotherapy response in breast cancer: a multicentre study. EClinicalMedicine 2025;85.
16. Jiang Y, Edwards AV, Newstead GM. Artificial Intelligence Applied to Breast MRI for Improved Diagnosis. Radiology 2021;298(1):38-46.
17. Winfield JM, Payne GS, Weller A, deSouza NM. DCE-MRI, DW-MRI, and MRS in cancer: challenges and advantages of implementing qualitative and quantitative multi-parametric imaging in the clinic. Topics in Magnetic Resonance Imaging 2016;25(5):245-254.
18. Lavini C, Verhoeff JJ, Majoie CB, Stalpers LJ, Richel DJ, Maas M. Model‐based, semiquantitative and time intensity curve shape analysis of dynamic contrast‐enhanced MRI: A comparison in patients undergoing antiangiogenic treatment for recurrent glioma. Journal of Magnetic Resonance Imaging 2011;34(6):1303-1312.
19. Li Z, Zhong Y, Wang Y. Exploring Kinetic Curves Features for the Classification of Benign and Malignant Breast Lesions in DCE-MRI. 2024 IEEE 37th International Symposium on Computer-Based Medical Systems (CBMS): IEEE, 2024; p. 496-501.
20. Liu Z, Yao B, Wen J, Wang M, Ren Y, Chen Y, Hu Z, Li Y, Liang D, Liu X. Voxel-wise mapping of DCE-MRI time-intensity-curve profiles enables visualizing and quantifying hemodynamic heterogeneity in breast lesions. European Radiology 2024;34(1):182-192.

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/562-02-009